Dose-proportionality, bioavailability, and steady-state kinetics of astemizole in man
โ Scribed by Jozef Heykants; Achiel van Peer; Robert Woestenborghs; Anton Jageneau; Gabriel Vanden Bussche
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 484 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Steady-state dose proportionality of mirtazapine, the active constituent of Remeronm tablets, a new antidepressant developed under the laboratory code Org 3770, was investigated. Each of 27 young healthy male subjects received a single daily oral dose of mirtazapine in the form of standard Remeronm
Serum and urine kinetics of unchanged tiracizine (T), a new class I antiarrhythmic agent, and three metabolites (Ml, 2, and 3) were assessed in eight healthy extensive metabolizers after a single oral administration of 50 mg tiracizine and during steady state (50 mg b.i.d.). Additionally, tiracizine
An aqueous solution containing 1 mg of adinazolam mesylate per ml was administered orally as a single dose (40mg) and with loading doses followed by hourly doses such that final dose rates of 1, 2, and 3mgh-' were administered to steady-state. Four subjects exhibited linear steady-state kinetics, wh